The Europe Ophthalmoscopes Market would witness market growth of 5.8% CAGR during the forecast period (2022-2028).
The increasing use of ophthalmoscopy in identifying the clinical aspects of several types of headaches in neurologic treatment has also contributed to expanding the market for ophthalmoscopes. In addition, a corpus of research has demonstrated the efficacy of funduscopy in relieving headaches in the patient population. The rise of the ophthalmoscopes market is driven by manufacturers' increased efforts to create awareness of technological advancements in ophthalmoscopes.
Moreover, rising healthcare spending for treating blindness, vision loss, and sight-threatening conditions is anticipated to increase demand for primary eye care & examinations, boosting the need for essential equipment like ophthalmoscopes during the projection period. The most common eye conditions requiring ophthalmoscopes are cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration. In industrialized nations, the rising prevalence of these disorders and improved access to eye care services have led to an increase in the use of ophthalmoscopes.
Approximately $30 billion is generated annually by the medical technology sector in the United Kingdom. It has a strong foundation of predominantly medium-sized enterprises nationwide, with activity centers in the South East of England and the Midlands. Furthermore, the United Kingdom is home to the headquarters or subsidiaries of many multinational corporations, including several of the largest medical technology producers. As a result of the region's developed medical device sector and the growing demand for innovative medical equipment, market participants have ample investment prospects in the region.
The Germany market dominated the Europe Ophthalmoscopes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $21.6 Million by 2028. The UK market is anticipated to grow at a CAGR of 4.9% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 6.6% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, Others. Based on Type, the market is segmented into Direct and Indirect. Based on Application, the market is segmented into Glaucoma, Diabetic Retinopathy, Macular Degeneration, Retinal Repair and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Ophthalmoscopes Market will Hit $332.9 Million by 2028, at a CAGR of 6.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc. (Welch Allyn) (Baxter International, Inc.), Keeler Ltd. (Halma Plc), Zumax Medical co. ltd, Albert Waeschle Limited, Neitz Instruments Co., Ltd., Iridex Corporation, HEINE Optotechnik GmbH & Co. KG, HONSUN Group, Nidek Co., Ltd., and Suzhou KangJie Medical, Inc.
By End-Use
By Type
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
